Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
University of Rochester NCORP Research Base
Status
Recruiting
NCT ID
NCT04888988
This phase II trial studies whether using exercise is better than the usual approach for treating chemotherapy-induced peripheral neuropathy (CIPN). CIPN occurs when chemotherapy damages the nerves communicating between the brain, spinal cord, and the rest of the body. The usual approach for treating CIPN is treatment with drugs that help reduce symptoms of other types of neuropathy (for example, from diabetes). However, these drugs do not treat all symptoms of CIPN. Exercise may help to reduce CIPN symptoms.
Intervention
Best Practice, Exercise Counseling, Exercise Intervention, Magnetic Resonance Imaging, Neuropathy Assessment, Questionnaire Administration
Condition
Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Investigators
Ian R Kleckner, Bryan A. Faller, Sarah E. Jax, Nicholas J. DiBella, Elie B. Choufani, Kendrith M. Rowland, Antonio J. Ruiz, Lucile L. Adams-Campbell, William A. Wilson, Elie G. Dib, Christa Braun-Inglis, Brian L. Burnette, Ki Y. Chung, Natalya Greyz-Yusupov, Site Public Contact, Gregory A. Masters, Richard L. Deming, Lili X. Wang, Bharat Jenigiri, Jay W. Carlson, Kathleen Y. Butler, Deborah W. Wilbur, Yan Zhao